Patients with impaired cell-mediated immunity, including those with advanced HIV infection, are highly susceptible to OPC. On page 299 of this issue, Conti et al. show that defense against OPC is more dependent on Th17-than Th-1-type immunity ( 6 ) . In this Commentary, we discuss this fi nding in light of unanswered questions about the pathogenesis of HIVassociated OPC.
Mouse models of candidiasis and relevance to human OPC Mouse models of candidiasis, including models of OPC, vaginitis, and disseminated disease, have been invaluable in advancing our understanding of the immune response to C. albicans . However, because the relationship between humans and C. albicans is unique, animal models do not fully recapitulate the human disease. Consequently, observations from animal models must be viewed in light of several important limitations.
First, mice do not have C. albicans among their commensal fl ora. Thus, murine infection with C. albicans is a de novo event that generates an acute immune response in a naive host. And inducing disease in mice requires inoculation with large doses of the fungus (typically 10 5 -7 yeasts), which is entirely diff erent from the scenario in humans, where C. albicans is part of the normal fl ora. Hence, early snapshots of the mouse immune response to C. albicans most likely refl ect an acute response, which is unlikely to occur in humans, in whom candidiasis occurs in a setting of prior infection/immunity. Although the number of organisms required to cause disease in humans is not known, human disease most likely refl ects an inability to control increased fungal growth in a particular tissue rather than a sudden high-dose challenge ( 1 ) . The cell type(s) that respond to a primary infection, and those that respond after a disturbance in commensalism, may or may not be the same.
In mice, Th17 responses have been implicated in mucosal immunity against fungal and bacterial infections in the lungs and gastrointestinal tract ( 7, 8 ) . In a mouse model of systemic candidiasis, IL-17 protected against infection by enhancing neutrophil recruitment ( 9 ) , whereas in gastric candidiasis, IL-17 -induced neutrophil activation caused excessive infl ammation ( 10 ) . Hence, the outcome of Th17 responses to C. albicans depends on the model, tissue, and/or microbe, suggesting that the link between Th17 immunity and resistance to OPC, as suggested by Conti et al., may not be completely straightforward.
The morphological state of C. albicans cells could also infl uence whether a Th1-or Th17-type immune response dominates in mouse models of candidiasis. Evidence for this possibility is suggested by in vitro studies with human cells showing that C. albicans hyphae induced the production of IL-23, a cytokine that drives the expansion and function of Th17 cells, whereas yeasts induced the production of IL-12, the signature inducer of Th1 immunity ( 11 ) . Although comparable evidence in mice is not available, this human precedent suggests that the state The disproportionate increase in oropharyngeal candidiasis (OPC) compared with systemic and vaginal candidiasis in female patients with AIDS has been a paradox for almost three decades. New data now show that severe OPC develops in Th17-defi cient mice, but not Th1-defi cient mice, implicating Th17-induced effector molecules in resistance to oral disease. These fi ndings clarify and extend our current thinking about how CD4 T cell defi ciency infl uences susceptibility to OPC. inadequate Th1 response ( 14, 15 ) . However, the identifi cation of the Th17 lineage opens up new avenues of investigation and provides an opportunity to dissect CD4 + T cell responses with greater precision.
In their study, Conti et al. compared the susceptibility to OPC in mice with impaired Th1 and/or Th17 responses. They found that fungal infections of the tongue were less severe in mice lacking IL-12p35 than in mice lacking IL-23p19, suggesting that Th17 responses play central role in control of infection. Compared with wild-type mice, however, the fungal burden in both IL12p35 -and IL-23p19 -defi cient mice was substantially higher (greater than three logs), demonstrating that the absence of either Th1 or Th17 cells compromised the ability of the mice to limit fungal growth ( Fig. 1 B ) , albeit to a lesser extent than observed when mice were immunosuppressed with cortisone.
Consistent with the known ability of the Th17 response to induce neutrophil recruitment, more neutrophils were recruited into the oral cavity in wild-type and relatively resistant IL-12p35 -defi cient mice than in the more susceptible IL-23p19 -defi cient mice. This fi nding links neutrophil recruitment to IL-17/Th17 and fungal clearance. However, because more neutrophils were recruited in IL-12p35 -defi cient than in wild-type mice, and these mice had higher fungal burdens, neutrophil depletion studies in IL-12p35 -defi cient mice might help dissect the relative role of neutrophils in fungal clearance versus infl ammation.
As mentioned, yeasts and hyphae preferentially induce human cells to produce IL-12 and IL-23, respectively ( 11 ) . Given that large numbers of yeasts are used to induce infection in most murine models of candidiasis, including the study by Conti et al., Th1-mediated candidacidal mechanisms could dominate soon after infection, with Th17-mediated control coming into play after the yeasts germinate into hyphae. Because the tissue response to OPC in wild-type mice was characterized by more neutrophils and a lower fungal burden than in either IL-12p35 -or detrimental eff ects of Th1-type immunity have been observed in infections in which Th1 cells were thought to be protective ( 10 ) , and in certain models of Th1-driven autoimmunity, mice lacking IL-12 remained susceptible ( 13 ) . Based on the Th1/Th2 paradigm and the well-known association between OPC and immunodefi ciency in human and mouse studies, the risk for OPC has been thought to stem from an of the fungus infl uences the polarization of the CD4 + T cell response. link between HIV infection and reduced IL-17 expression suggests the possibility of divergent roles for IL-17 in the pathogenesis of HIV-associated OPC. In early HIV infection, when Th17 cells are more prevalent, IL-17 signaling could provide protection against OPC by attracting neutrophils. In some instances, however, excessive IL-17 -mediated infl ammation could be detrimental, particularly if Th1 immunity is impaired. Alternatively, depletion of IL-17 -producing CD4 + T cells from the gastrointestinal tract or during chronic HIV infection could be associated with a higher mucosal fungal burden, including in the oral cavity.
Ultimately, the balance between Th1 and Th17 immunity could infl uence the balance between infl ammation and fungal clearance and could determine whether OPC develops ( 10, 16 ) . The same concept may apply to vaginal candidiasis. Several studies have demonstrated that vaginal colonization with C. albicans is more prevalent in HIVinfected women than in HIV-uninfected women and that higher viral loads are associated with increased colonization ( 31 -34 ) . In most studies, however, neither disease nor disease severity is increased in the setting of HIV infection, and disease does not correlate with CD4 + T cell levels ( 31, 32, 35 ) , suggesting that other factors contribute more to disease pathogenesis and severity than defects in CD4 + T cell responses ( 36 ) . Diff erences in immune control of C. albicans proliferation and/ or infl ammation-mediated host damage are likely to diff er in the oral and vaginal milieus, which have markedly diff erent microbiota. For example, in the vagina, local control of bacteria is aff ected primarily by innate immunity, including epithelial cells, and by the fungal-inhibiting eff ects of the bacterial fl ora, whereas adaptive immunity has a less prominent role ( 36 ) .
Paradigms for resistance to OPC: Th cell redux By design, experimental models hold either the microbe or host constant while varying the other. At present, the degree to which mucosal damage in nants, phase transition, and gene expression) and/or host factors (receptors, cytokines/chemokines, and genetics). Indeed, the importance of host genetics in governing Th17 responses was recently demonstrated by the discovery that mutations in STAT3 and IL12RB1 impair the production of IL-17 by T cells ( 21 ) . + T cells from chronically infected individuals, nonprogressors, and patients on highly active antiretroviral therapy (HAART) produced less IL-17 ( 22 ) . HAART reduces the frequency of OPC without reducing fungal burden ( 23 ) , and the development of OPC in patients receiving HAART has been linked to a failure of immune reconstitution ( 24, 25 ) . On the other hand, oral candidiasis has been observed in association with immune reconstitution ( 26, 27 ) . Hence, the relationship between OPC and HIV-associated CD4 + T cell levels is not straightforward. In mice, depletion of CD4 T cells alone did not increase experimental OPC ( 28 ). However, depletion of neutrophils or macrophages in addition to CD4 + T cells enhanced the severity of disease ( 28 ) . In another mouse model, IL-12p40 -defi cient mice were susceptible to OPC, but not systemic candidiasis, a fi nding that the authors attributed to the ability of innate immune mechanisms to clear systemic candidiasis, but not oral candidiasis, which requires the generation of an adaptive immune response ( 29 ) .
OPC in HIV infection
IL-17 -producing CD4 + T cells were found to be preferentially depleted from the gastrointestinal tract of HIV-infected individuals ( 30 ) . This IL-23p19 -defi cient mice, Th1 and Th17 eff ector mechanisms probably synergize to maximize fungal clearance and to minimize tissue damage that arises during clearance.
Synergy between Th1 and Th17 responses occurs in other infection models. For example, in a mouse model of Cryptococcus neoformans , IL-23 enhanced Th1-type immunity and fungal clearance ( 16 ) . In OPC, neutrophils might enhance infl ammatory pathology in IL-12p35 -defi cient mice, whereas their absence probably impairs fungal clearance in Th17-defi cient mice. The benefi t of IL-17 -induced infl ammation varies in diff erent experimental models ( 10, (16) (17) (18) . Clearly, more information is needed to fully understand the role that IL-17 -mediated infl ammation plays in resistance and susceptibility to OPC.
The mechanism by which Th17 immunity leads to resistance to OPC was suggested by Conti et al. to involve both IL-17 -induced neutrophil recruitment and direct IL-17 -induced antimicrobial eff ects. Indeed, the expression of Th17-inducible genes, including neutrophil activating factors, neutrophil-attracting CXC chemokines, and antimicrobial peptides, was greater in the oral mucosa of wild-type mice than of susceptible IL-17RA -defi cient mice. Moreover, saliva from wild-type mice could kill the fungus in vitro, whereas the killing capacity of saliva from IL-23p19 -and IL-17RA -defi cient mice was impaired. These data are consistent with previous studies showing that IL-23, in concert with IL-17, induced the production of antimicrobial peptides, including ␤ defensins, from mouse keratinocytes ( 19 ) and that patients with OPC had reduced expression of ␤ defensins ( 20 ) .
However, association is not causation, and the reported diff erences in the cytokines that drive Th17 expansion and diff erentiation in mice and humans suggest the need for caution in directly extrapolating these mouse fi ndings to human OPC. The ability of Th17-polarized cells to trigger the production of ␤ defensins in OPC could be a function of microbial factors (antigenic determi-that is likely to fuel new hypotheses and experimental approaches that could help unravel this mystery.
OPC results from microbial factors (yeasts, hyphae, or fungal invasion) or host factors (infl ammatory response, genetics, or both) is unknown. In murine vaginal candidiasis, mucosal damage results from an exuberant host infl ammatory response to fungal proliferation ( 37 ) .
Th17-defi cient mice in the study by Conti et al. had impaired neutrophil recruitment and high fungal burdens. More work is needed to understand whether Th17 responses also govern the response to vaginal candidiasis in mice, although data suggest that neutrophils contribute more to the symptoms associated with vaginitis than they provide protection against disease ( 36 ) . Ultimately, human studies of OPC are needed, because it is unclear whether mouse and human diseases have the same etiology. In humans, OPC has diverse etiologies ranging from antimicrobial use, to immune dysregulation associated with advanced HIV infection, to mutations in autoimmune regulator genes. Among patients with chronic mucocutaneous candidiasis, there are profound diff erences in cytokine production, including IL-23, depending on the etiology of the disorder ( 38 ) . The extent to which Th17 polarization is antigen-driven is also not known ( 30 ) . Although HIV infection and host genetics are likely to be important variables in Th17 expression, environmental factors, particularly those that aff ect the microbiota, could also infl uence Th cell polarization. Finally, although microbe-specifi c motifs could drive Th polarization, common microbial motifs that induce Th1 or Th17 may also be present. Hence, a diverse group of microbial ligands could induce Th1 or Th2, or Th17, not unlike the diverse ligands that trigger signaling from diff erent TLRs, and microbial immunity could be less specifi c than previously thought.
In light of the many unknowns discussed here, the mechanism/s underlying the predilection for HIV-infected persons to develop OPC, rather than other forms of candidiasis, remains unexplained. Nonetheless, the article by Conti et al. suggests a new twist to understanding the pathogenesis of OPC
